Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support

Abstract

Conventional dose induction therapy followed by consolidation with high dose therapy and ABMR is well tolerated and provides prolonged disease-free survival in some patients with chemosensitive relapsed germ cell cancer.